News – Page 473 – Endpoints News

From Australia, new $173M research center strives to be at the forefront of pandemic drug discovery

3 years ago

Microcap cardio player touts a 'sizable' tech deal with Bayer's BlueRock in wake of 'going concern' alert

3 years ago

Amgen posts terse update on PhIII Lumakras win — but just how big?

3 years ago

Pharma-backed patient groups sue HHS over copay assistance programs

3 years ago

Florida sues FDA over dragging its feet on Canadian drug import program's approval

3 years ago

Corrected: FDA allows Curis to restart enrolling patients in leukemia trial as shares tumble 9%

3 years ago

Australian manufacturer acquired by capital investment firm with experience in CDMO space

3 years ago

Genentech opens new $250M biologics manufacturing site in South San Francisco

3 years ago

Medtronic taps former Disney star Jennifer Stone to promote insulin pen

3 years ago

Pfizer picks up first chief marketing officer from big tech Alphabet’s Verily

3 years ago

Trapped in Nasdaq’s biotech basement, Codiak’s Doug Williams lays out a survival plan: chopping jobs, PhII plans

3 years ago

Pharma's day in court: Is the daily downpour of lawsuits giving pharma companies a bad rep?

3 years ago

MarketingRx roundup: J&J cyclists hit the road for annual cancer research ride; Gilead, Pfizer top patient view in ...

3 years ago

Latest Covid-19 shots are almost ready: Why is the US authorizing a different booster than the rest of the world?

3 years ago

Illumina taps tennis star Chris Evert for its first genomics forum alongside Barack Obama and Bill Gates

3 years ago

Food allergy biotech gets $50M loan; Sean Ianchulev’s medical device company raises a $23M Series B

3 years ago

In five patients, Sangamo’s Fabry disease gene therapy appears to be working so far

3 years ago

Sanofi nabs priority review for hemophilia A program as pharma awaits FDA decision

3 years ago

Two years after PhII setback, Jounce's lead I/O drug flops again despite biomarker approach

3 years ago

Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold

3 years ago

A Stone Capital-backed SPAC braves the blank check waters, looking to grab a $150M deal

3 years ago

With cash in the bank and an eye on Europe, Neurocrine buys out a London-based outfit

3 years ago

#ESC22: In return to ‘big chronic diseases,’ Europe’s cardio confab showcases mixed bag of data drops

3 years ago

China's DNA giant confronts skepticism in US expansion bid

3 years ago

First page Previous page 470 471 472473474 475 476 Next page Last page